Advertisement

Topics

AstraZeneca GmbH Company Profile

06:59 EDT 20th June 2018 | BioPortfolio

Forschungsförderpreis – Imaging in Psychiatrie und Psychotherapie Der Preis wird während der DGPPN-Mitgliederversammlung, die im R ahmen des diesjährigen DGPPN-Kongresses in Berlin stattfindet, verliehen und soll für einen Forschungsaufenthalt im Ausland genutzt werden.
Ziel ist es, junge Wissenschaftler aus allen Fachbereichen, die bereits erste Erfahrungen mit Bildgebungsmethoden im Bereich der Psychiatrie und Psychotherapie gesammelt haben, durch einen mehr monatigen Auslandsaufenthalt in einem Labor höchster Exzellenz zu fördern. Dieser Aufenthalt ist innerhalb von zwölf Monaten nach der Preisverleihung durchzuführen. Antragsberechtigt sind alle Jungwissenschaftler (z.B. Mediziner, Psychologen, Physiker), die nicht älter als 35 Jahre sind.

Location

Johannisberger Straße 74 14197
Postfach
140201
Germany

Contact

Phone: (030) 884293 - 0
Fax: (030) 884293 - 41
Email: info@bsmo.de


News Articles [789 Associated News Articles listed on BioPortfolio]

AstraZeneca darf Krebsimmuntherapie auf den Markt bringen: Durchbruch für AstraZeneca: Das Medikament ...

Durchbruch für AstraZeneca: Das Medikament Imfinzi des Pharma-Konzerns wurde als Arznei gegen Lungenkrebs zugelassen. Nun winken Milliarden-Einnahmen.AstraZeneca hat von der US-Gesundheitsbehörde F....

AstraZeneca BioVenture Hub: A new way of building companies fast

Magus Bjorsne, CEO of AstraZeneca's BioVenture Hub, discusses how the capability, experience and expertise of AstraZeneca in helping mature Biotechs transition into product development.

Syndax partners with AstraZeneca for immuno-oncology clinical trials

Syndax Pharmaceuticals and AstraZeneca have agreed to evaluate the safety and efficacy of AstraZeneca's durvalumab in combination with the former's SNDX-6352 across a variety of solid tumors.

M&As this week: AstraZeneca, Mega Labs, Toho Holdings

AstraZeneca has agreed to purchase an additional 5.7% stake in Circassia Pharmaceuticals in a cash transaction. AstraZeneca’s total share in the...Read More... The post M&As this week: AstraZe...

AstraZeneca Pulls Back Off Best Levels But Remains Positive

LONDON (dpa-AFX) - After showing a strong upward move early in the session, shares of AstraZeneca (AZN) have given back some ground but remain positive in afternoon trading on Friday. AstraZeneca ...

Tim Herpin, AstraZeneca: Achieving scientific leadership and restoring growth

In this interview filmed at BIO Europe in Vienna, Paul Larsmon talks to Tim Herpin, Vice President, Head of transactions, Business development, GPPS, AstraZeneca. They discuss the change in strategy a...

AstraZeneca secures European approval for asthma drug

Biopharmaceutical company AstraZeneca has received approval from the European Commission (EC) for its asthma medicine Fasenra. Results from AstraZeneca's Phase III WINDWARD programme demonstrated a...

AstraZeneca Hovering Firmly In Positive Territory

LONDON (dpa-AFX) - After gapping open higher, shares of AstraZeneca (AZN) are hovering in positive territory in afternoon trading on Friday. AstraZeneca is currently up by 1.2 percent after reachi...

PubMed Articles [18 Associated PubMed Articles listed on BioPortfolio]

Medical Science Liaisons in Real-World Evidence Studies: Experience of AstraZeneca Russia.

There is no doubt that real-world evidence studies have the potential to improve and accelerate the development and delivery of safe and cost-effective innovative medicines to patients as well as infl...

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

Postoperative Corneal Asphericity in Low, Moderate, and High Myopic Eyes After Transepithelial PRK Using a New Pulse Allocation.

To evaluate the postoperative asphericity in low, moderate, and high myopic eyes after combined transepithelial photorefractive keratectomy and SmartSurfACE treatment (SCHWIND eye-tech-solutions GmbH,...

Clinical Trials [82 Associated Clinical Trials listed on BioPortfolio]

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis

This study is to evaluate non inferiority of Eurofarma budesonide nasal spary x referral Astrazeneca budesonide. Half patients will receive Eurofarma medication and half patients will rece...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bio Equivalence Study of Torrent Pharmaceutical Ltd's Rosuvastatin Calcium Tablets Under Fasting Condition.

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions

Subjects to compare the single dose bioavailability of Torrent's Esomeprazole Magnesium DR Capsules 40 mg and Nexium® 40 mg DR Capsules of AstraZeneca LP, USA. Dosing periods of studies w...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [598 Associated Companies listed on BioPortfolio]

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestin...

AstraZeneca Pharmaceuticals LP

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a lead...

AstraZeneca and The Medicines Company

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastro...

AstraZeneca HealthCare Foundation

Established in 1993, the AstraZeneca HealthCare Foundation is a Delaware not-for-profit corporation and a 501(c)(3) entity organized for charitable purposes including to promote p...

AstraZeneca AS

AstraZeneca er et av verdens ledende farmasøytiske selskaper. Vi bruker hvert år ca. 25 milliarder norske kroner på forskning verden over for å utvikle nye medisiner. Dette har resultert i en rekk...

More Information about "AstraZeneca GmbH" on BioPortfolio

We have published hundreds of AstraZeneca GmbH news stories on BioPortfolio along with dozens of AstraZeneca GmbH Clinical Trials and PubMed Articles about AstraZeneca GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AstraZeneca GmbH Companies in our database. You can also find out about relevant AstraZeneca GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record